跳至主要内容
临床试验/NCT00042848
NCT00042848已完成3 期

Phase III Randomized, Placebo-Controlled, Double-Blind Trial Of The Effect Of Modafinil On Fatigue In Cancer Patients Receiving Chemotherapy

Gary Morrow70 个研究点 分布在 1 个国家目标入组 837 人开始时间: 2002年8月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Gary Morrow
入组人数
837
试验地点
70
主要终点
Efficacy to reduce fatigue during chemotherapy as assessed by the Brief Fatigue Inventory at course 4

研究概览

简要总结

RATIONALE: Modafinil may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy. The effectiveness of modafinil in relieving chemotherapy-related fatigue is not yet known.

PURPOSE: This randomized phase III trial is studying the effectiveness of modafinil in treating fatigue in patients who are receiving chemotherapy for cancer.

详细描述

OBJECTIVES:

  • Assess the degree to which modafinil can reduce fatigue in cancer patients receiving chemotherapy.
  • Assess the relationship between depression and fatigue in patients treated with this drug.

OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Beginning on day 5 of the second course of chemotherapy, patients receive oral modafinil once daily.
  • Arm II: Beginning on day 5 of the second course of chemotherapy, patients receive oral placebo once daily.

Treatment in both arms continues until day 7 of course 4 of chemotherapy in the absence of disease progression or unacceptable toxicity.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Supportive Care
盲法
Double

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Efficacy to reduce fatigue during chemotherapy as assessed by the Brief Fatigue Inventory at course 4

次要结局

  • Relationship between depression and fatigue during chemotherapy as assessed by Fatigue Symptom Checklist, Profile of Mood States, Fatigue Severity Scale, Epworth Sleepiness Scale, Center for Epidemiologic Studies-Depression, and Mini-Mac at course 4

研究者

发起方
Gary Morrow
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Gary Morrow

Director, URCC NCORP Research Base

University of Rochester NCORP Research Base

研究点 (70)

Loading locations...

相似试验